Description

D-Xylofuranose (9Ci) is a specialized monosaccharide derivative, a key chiral building block and intermediate in organic synthesis. Its significance lies in its role as a precursor for nucleoside analogs, carbohydrate-based pharmaceuticals, and complex natural products. This high-purity compound is essential for researchers and manufacturers in the pharmaceutical, biotechnology, and fine chemical industries, particularly those developing antiviral agents, enzyme inhibitors, and novel glycosylation methodologies. CAS No. 36441-93-7.

Application

• Pharmaceutical Intermediate: Critical starting material for the synthesis of nucleoside analogs with potential antiviral or anticancer activity.
• Biochemical Research: Used as a substrate or inhibitor in enzymatic studies, particularly those involving carbohydrate-processing enzymes.
• Glycochemistry: Serves as a fundamental building block for the construction of complex oligosaccharides, glycoconjugates, and glycomimetics.
• Fine Chemical Synthesis: Employed as a chiral pool reagent for the asymmetric synthesis of natural products and other bioactive molecules.
• Diagnostic Reagent Development: Potential use in the formulation of reagents for detecting specific enzymes or metabolic pathways.

Basic Information

Product Name	D-Xylofuranose (9Ci)
CAS No.	36441-93-7
Molecular Formula	C5H10O5
Molecular Weight	150.13 g/mol
Synonyms	D-Xylofuranose; Xylofuranose; (3R,4S,5R)-Tetrahydro-3,4,5-trihydroxy-2-furanmethanol; 2-Deoxy-D-erythro-pentofuranose; D-(-)-Xylofuranose; α-D-Xylofuranose; β-D-Xylofuranose; D-Xylose, cyclic form
EINECS	Contact for details

Quality Control

Our D-Xylofuranose (9Ci) is produced under stringent quality management systems to ensure batch-to-batch consistency and high purity. Each lot undergoes comprehensive analytical testing, including HPLC for assay and purity, optical rotation measurement, and residual solvent analysis. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting compliance with agreed specifications. We support cGMP standards for pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept under dry, inert conditions to prevent decomposition. For long-term storage, consider storing under an inert atmosphere such as argon or nitrogen.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Assay (HPLC)	≥ 98.0%
Optical Rotation [α]²⁰D	-75° to -85° (c=1 in H₂O)
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.